Home          View all 329 MoA classes  

      

Enter a class name or drug name above to search the database.

Glucosylceramide Synthase Inhibitors [MoA] Mechanism of Action Drugs

NDC Number Brand Name Generic Name Labeler Dosage Form DEA Schedule Marketing Start Date
10148-201 Miglustat miglustat CoTherix, Inc. CAPSULE 2018-04-25
42799-709 Yargesa Miglustat Edenbridge Pharmaceuticals LLC. CAPSULE 2020-08-06
43975-310 MIGLUSTAT MIGLUSTAT ANI Pharmaceuticals, Inc. CAPSULE 2018-04-17
58468-0220 Cerdelga eliglustat Genzyme Corporation CAPSULE 2014-09-03
66215-201 Zavesca miglustat Actelion Pharmaceuticals US, Inc. CAPSULE 2003-07-31
68475-204 Miglustat Miglustat Navinta LLC CAPSULE 2025-05-07
70710-2039 Miglustat Miglustat Zydus Pharmaceuticals USA Inc. CAPSULE 2025-04-01
71904-300 OPFOLDA miglustat AMICUS THERAPEUTICS US, LLC CAPSULE 2023-10-11

 Mechanism of Action Classification 

Loading full table content...